Bay-y-1015 [CAS 133012-05-2]

Bay-y-1015 is an orally active quinoline-based 5-lipoxygenase inhibitor. Bay-y-1015 inhibits LTB4 and LTC4 synthesis. Bay-y-1015 can be used in the research of inflammatory diseases[1].

[133012-05-2]

C26H30N2O4S

466.59

O=C(NS(=O)(C)=O)[C@H](C1CCCCCC1)C(C=C2)=CC=C2OCC3=NC4=CC=CC=C4C=C3

Lipoxygenase

5-LOX

Room temperature